Concentrated liquid pharmaceutical formulations of furosemide
US11497755B2 · kind B2 · utility
0Cited by
9References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 18, 2022 |
| Grant date | Nov 15, 2022 |
| Priority date | — |
| Expiry date | Feb 18, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M5/14248
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein, in part, are liquid pharmaceutical formulations comprising furosemide or a pharmaceutically acceptable salt thereof, one or more pharmaceutically acceptable excipients, and a pharmaceutically acceptable buffer. Methods of treating congestion, edema, fluid overload, or hypertension in a patient in need thereof are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.